Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 12, 2023
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
Tue, April 11, 2023
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
[ Tue, Apr 11th 2023
] - WOPRAI
Jacob Johnson Upgraded (WST) to Buy and Increased Target to $400 on, Apr 11th, 2023
Jacob Johnson of Stephens & Co., Upgraded "West Pharmaceutical Services, Inc." (WST) to Buy and Increased Target from $330 to $400 on, Apr 11th, 2023.
Jacob has made no other calls on WST in the last 4 months.
There are 2 other peers that have a rating on WST. Out of the 2 peers that are also analyzing WST, 1 agrees with Jacob's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Justin Bowers of "Deutsche Bank" Initiated at Hold and Held Target at $250 on, Wednesday, December 14th, 2022
This is the rating of the analyst that currently disagrees with Jacob
- Paul Knight of "Keybanc" Maintained at Buy with Increased Target to $375 on, Friday, February 17th, 2023
